Why BTIG Upgraded the Shares Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts ...

The Lapiplasty procedure has also shown a low recurrence rate. Studies show up to 99 percent of patients do not have a recurrence of the bunion 17 months after the surgery. Lapiplasty 3D bunion ...

It also supports the healing process with a unique fixation method that complements Treace's existing Lapiplasty and Adductoplasty procedures. "We're excited to expand our best-in-class bunion ...

Why BTIG Upgraded the Shares Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently introduced a new technique called the ...